Mendota Financial Group LLC Acquires 978 Shares of CVS Health Co. (NYSE:CVS)

Mendota Financial Group LLC increased its stake in CVS Health Co. (NYSE:CVS) by 32,600.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 981 shares of the pharmacy operator’s stock after purchasing an additional 978 shares during the period. Mendota Financial Group LLC’s holdings in CVS Health were worth $44,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of CVS. Grandview Asset Management LLC purchased a new position in CVS Health in the fourth quarter worth $311,000. Marcum Wealth LLC boosted its holdings in shares of CVS Health by 17.2% in the 4th quarter. Marcum Wealth LLC now owns 8,723 shares of the pharmacy operator’s stock worth $392,000 after purchasing an additional 1,283 shares in the last quarter. Persium Advisors LLC bought a new position in shares of CVS Health during the 4th quarter valued at about $323,000. Bridge Creek Capital Management LLC raised its holdings in shares of CVS Health by 0.6% during the 4th quarter. Bridge Creek Capital Management LLC now owns 57,767 shares of the pharmacy operator’s stock valued at $2,593,000 after buying an additional 330 shares in the last quarter. Finally, Moody National Bank Trust Division lifted its position in CVS Health by 3.8% in the 4th quarter. Moody National Bank Trust Division now owns 24,185 shares of the pharmacy operator’s stock worth $1,086,000 after buying an additional 885 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

CVS Health Trading Up 7.4 %

NYSE CVS opened at $51.54 on Tuesday. The stock’s fifty day moving average price is $51.76 and its 200-day moving average price is $56.49. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The stock has a market cap of $64.86 billion, a P/E ratio of 13.08, a P/E/G ratio of 0.85 and a beta of 0.59. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s revenue was up 6.3% compared to the same quarter last year. During the same period last year, the business earned $2.21 EPS. As a group, equities analysts forecast that CVS Health Co. will post 5.32 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.16%. The ex-dividend date is Thursday, January 23rd. CVS Health’s payout ratio is 67.51%.

Analyst Ratings Changes

CVS has been the topic of several research reports. UBS Group boosted their price objective on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. Deutsche Bank Aktiengesellschaft upgraded shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target for the company in a research report on Tuesday, December 3rd. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $60.00 to $66.00 in a report on Monday, November 18th. Cantor Fitzgerald restated a “neutral” rating and set a $62.00 target price on shares of CVS Health in a report on Tuesday, October 1st. Finally, TD Cowen lifted their price target on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research note on Monday, November 25th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, CVS Health has an average rating of “Moderate Buy” and a consensus price target of $68.71.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.